Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1992;85:1110-1117

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flugelman, M. Y.
Right arrow Articles by Dichek, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flugelman, M. Y.
Right arrow Articles by Dichek, D. A.

Circulation, Vol 85, 1110-1117, Copyright © 1992 by American Heart Association


ARTICLES

Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter

MY Flugelman, MT Jaklitsch, KD Newman, W Casscells, GL Bratthauer and DA Dichek
Molecular Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.

BACKGROUND. Gene transfer into the arterial wall may provide a novel therapeutic strategy for the treatment of coronary artery restenosis. Previously described methods for gene transfer into the arterial wall require total vessel occlusion for 30 minutes. We sought to develop a protocol for gene transfer within a more clinically relevant time frame. METHODS AND RESULTS. We used a perforated balloon (Wolinsky) catheter to inject retroviral vector-containing virions into rabbit aortas in vivo. The virions were injected within 1 minute. Aortas were removed 5-14 days after injection and analyzed for evidence of gene transfer. In initial studies, nine rabbits were injected with a vector expressing the beta-galactosidase gene, and nine rabbits were injected with either non-beta-galactosidase-containing vectors or with a vehicle control. Histochemical staining of aortic tissues revealed blue (positive) cells in eight of nine experimental rabbits and six of nine controls. Because of the lack of specificity of the beta-galactosidase detection system, we adopted a polymerase chain reaction-based protocol in which oligonucleotide primers were used to amplify specific vector- related sequences from aortic tissue extracts. The polymerase chain reaction protocol, calibrated with standards containing known numbers of transduced cells, revealed low amounts of vector-related sequences in six of 12 vector-injected rabbits and in one of 13 controls (p less than 0.03). Comparison with standards indicated that fewer than 100 transduced cells were present in a 2-cm length of the injected aortic tissue. CONCLUSIONS. Although in vivo gene transfer through an infusion balloon catheter can be accomplished within 1 minute, the therapeutic use of this protocol is limited by the small number of cells that are transduced.


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
F. Sharif, K. Daly, J. Crowley, and T. O'Brien
Current status of catheter- and stent-based gene therapy
Cardiovasc Res, November 1, 2004; 64(2): 208 - 216.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
B. S. Zuckerbraun and E. Tzeng
Vascular Gene Therapy: A Reality of the 21st Century
Arch Surg, July 1, 2002; 137(7): 854 - 861.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Yap, C. Pellegrini, T. O'Brien, H. D. Tazelaar, and C. G.A. McGregor
Conditions of vector delivery improve efficiency of adenoviral-mediated gene transfer to the transplanted heart
Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 702 - 707.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Ooboshi, S. Ibayashi, J. Takada, H. Yao, T. Kitazono, and M. Fujishima
Adenovirus-Mediated Gene Transfer to Ischemic Brain : Ischemic Flow Threshold for Transgene Expression
Stroke, April 1, 2001; 32(4): 1043 - 1047.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. K. Das, R. M. Engelman, N. Maulik, J. A. Rousou, J. E. Flack III, and D. W. Deaton
Molecular targets of gene therapy
Ann. Thorac. Surg., November 1, 1999; 68(5): 1929 - 1933.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Baek and K. L. March
Gene Therapy for Restenosis : Getting Nearer the Heart of the Matter
Circ. Res., February 23, 1998; 82(3): 295 - 305.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. B. DeYoung and D. A. Dichek
Gene Therapy for Restenosis : Are We Ready?
Circ. Res., February 23, 1998; 82(3): 306 - 313.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. J Feldman and G. Steg
Optimal techniques for arterial gene transfer
Cardiovasc Res, September 1, 1997; 35(3): 391 - 404.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Vassalli and D. A Dichek
Gene therapy for arterial thrombosis
Cardiovasc Res, September 1, 1997; 35(3): 459 - 469.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Maeda, U. Ikeda, Y. Ogasawara, M. Urabe, T. Takizawa, T. Saito, P. Colosi, G. Kurtzman, K. Shimada, and K. Ozawa
Gene transfer into vascular cells using adeno-associated virus (AAV) vectors
Cardiovasc Res, September 1, 1997; 35(3): 514 - 521.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. F. Dunn, K. D. Newman, M. Jones, I. Yamada, V. Shayani, R. Virmani, and D. A. Dichek
Seeding of Vascular Grafts With Genetically Modified Endothelial Cells : Secretion of Recombinant TPA Results in Decreased Seeded Cell Retention In Vitro and In Vivo
Circulation, April 1, 1996; 93(7): 1439 - 1446.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Lee, H. Laks, D. C. Drinkwater, A. Blitz, L. Lam, Y. Shiraishi, P. Chang, T. A. Drake, and A. Ardehali
CARDIAC GENE TRANSFER BY INTRACORONARY INFUSION OF ADENOVIRUS VECTOR--MEDIATED REPORTER GENE IN THE TRANSPLANTED MOUSE HEART
J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 246 - 252.
[Abstract] [Full Text]


Home page
CirculationHome page
P. Zoldhelyi, J. McNatt, X.-M. Xu, D. Loose-Mitchell, R. S. Meidell, F. J. Clubb Jr, L. M. Buja, J. T. Willerson, and K. K. Wu
Prevention of Arterial Thrombosis by Adenovirus-Mediated Transfer of Cyclooxygenase Gene
Circulation, January 1, 1996; 93(1): 10 - 17.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. Yao and D. H. Wang
Heterogeneity of Adenovirus-Mediated Gene Transfer in Cultured Thoracic Aorta and Renal Artery of Rats
Hypertension, December 1, 1995; 26(6): 1046 - 1050.
[Abstract] [Full Text]


Home page
CirculationHome page
Y. Sawa, K. Suzuki, H.-Z. Bai, R. Shirakura, R. Morishita, Y. Kaneda, and H. Matsuda
Efficiency of In Vivo Gene Transfection Into Transplanted Rat Heart by Coronary Infusion of HVJ Liposome
Circulation, November 1, 1995; 92(9): 479 - 482.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
H. Ooboshi, M. J. Welsh, C. D. Rios, B. L. Davidson, and D. D. Heistad
Adenovirus-Mediated Gene Transfer In Vivo to Cerebral Blood Vessels and Perivascular Tissue
Circ. Res., July 1, 1995; 77(1): 7 - 13.
[Abstract] [Full Text]


Home page
ScienceHome page
R. Mulligan
The basic science of gene therapy
Science, May 14, 1993; 260(5110): 926 - 932.
[Abstract] [PDF]


Home page
CirculationHome page
Y. Taniyama, K. Tachibana, K. Hiraoka, T. Namba, K. Yamasaki, N. Hashiya, M. Aoki, T. Ogihara, K. Yasufumi, and R. Morishita
Local Delivery of Plasmid DNA Into Rat Carotid Artery Using Ultrasound
Circulation, March 12, 2002; 105(10): 1233 - 1239.
[Abstract] [Full Text] [PDF]